Cargando…

Graves’ disease following SARS-CoV-2 vaccination

Detalles Bibliográficos
Autores principales:	Sriphrapradang, Chutintorn, Shantavasinkul, Prapimporn Ch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514605/ https://www.ncbi.nlm.nih.gov/pubmed/34648112 http://dx.doi.org/10.1007/s12020-021-02902-y

Ejemplares similares

Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
por: Sriphrapradang, Chutintorn
Publicado: (2021)

Postprandial hypoglycemia after ileocolic interposition and Billroth‐II gastrojejunostomy: A case report
por: Unhapipatpong, Chanita, et al.
Publicado: (2023)

Diagnosis and Management of Graves' Disease in Thailand: A Survey of Current Practice
por: Sriphrapradang, Chutintorn
Publicado: (2020)

Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2016)

Two further cases of Graves’ disease following SARS-Cov-2 vaccination
por: Zettinig, G., et al.
Publicado: (2021)

Acute interstitial nephritis following SARS-CoV-2 vaccination
por: Wu, Henry H L, et al.
Publicado: (2021)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
por: Weintraub, Michael A., et al.
Publicado: (2021)

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
por: Khayat-Khoei, Mahsa, et al.
Publicado: (2021)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Chronic spontaneous urticaria following vaccination against SARS-CoV-2()
por: Zaiem, Ahmed, et al.
Publicado: (2022)

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
por: Figueiredo, J.C., et al.
Publicado: (2022)

Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)

Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
por: Holzworth, Amy, et al.
Publicado: (2021)

Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
por: Rocco, Alba, et al.
Publicado: (2021)

Polyradiculitis and encephalomyelitis in the same patient following a SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2022)

Myelin oligodendrocyte glycoprotein associated disorder following SARS-CoV-2 vaccination
por: Bellakhdar, S., et al.
Publicado: (2022)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Parsonage Turner Syndrome Following Vaccination With mRNA-1273 SARS-CoV-2 Vaccine
por: Bernheimer, James H., et al.
Publicado: (2022)

Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
por: Schwotzer, Nora, et al.
Publicado: (2021)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2
por: Oniszczuk, Julie, et al.
Publicado: (2021)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Post-SARS-CoV-2 Vaccine Monitoring of Disease Flares in Autoinflammatory Diseases
por: Alehashemi, Sara, et al.
Publicado: (2022)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d35ocfv91c41eionmj7tqm16e0